ABT — Abbott Laboratories · P/E 25, rev $44.33B

Abbott Laboratories (ABT) is a medical devices company listed on NYSE.

Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. ABT currently screens at market cap $154.15B and trailing P/E 24.8.

Use this ABT page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ABT quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ABT SEC filings page. Lician reads the product cache first so this HTML stays unique to Abbott Laboratories even when a live quote feed is slow.